Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hyung-Joo Oh

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 16

Top Venues

PloS one

Cancers

Cells

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Cheol-Kyu Park, Nakyung Jeon, Hwa-Kyung Park, Hyung-Joo Oh, Young-Chul Kim, Ha Lim Jeon, Yong-Hyub Kim, Sung-Ja Ahn, In Jae Oh
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (5) (2023)
Cheol-Kyu Park, Sung-Woo Lee, Hyun-Ju Cho, Hyung-Joo Oh, Young-Chul Kim, Yong-Hyub Kim, Sung Ja Ahn, Jae-Ho Cho, In Jae Oh
Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (4) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Cheol-Kyu Park, Sung-Woo Lee, Hyun-Ju Cho, Hyung-Joo Oh, Young-Chul Kim, Yong-Hyub Kim, Sung Ja Ahn, Jae-Ho Cho, In Jae Oh
Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (4) (2023)
Cheol-Kyu Park, Nakyung Jeon, Hwa-Kyung Park, Hyung-Joo Oh, Young-Chul Kim, Ha Lim Jeon, Yong-Hyub Kim, Sung-Ja Ahn, In Jae Oh
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (5) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Cheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, Ji-Young Lee, Hyun-Ju Cho, Young-Chul Kim, Jeong Eun Lee, Seong Hoon Yoon, Chang-Min Choi, Jae Cheol Lee, Sung-Yong Lee, Shin Yup Lee, Sung-Min Chun, In Jae Oh
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial. Cells 12 (9) (2023)
Min-Gwan Sun, Sue Jee Park, Yeong Jin Kim, Kyung-Sub Moon, In-Young Kim, Shin Jung, Hyung-Joo Oh, In Jae Oh, Tae-Young Jung
Intracranial Efficacy of Systemic Therapy in Patients with Asymptomatic Brain Metastases from Lung Cancer. Journal of clinical medicine 12 (13) (2023)
Young-Ok Na, Hwa Kyung Park, Jae-Kyeong Lee, Bo-Gun Kho, Tae-Ok Kim, Hong Joon Shin, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hyung-Joo Oh, Cheol-Kyu Park, In Jae Oh, Young-Chul Kim, Ha-Young Park
Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study. PloS one 17 (12) (2022)
Tae-Ok Kim, Young-Ok Na, Hwa Kyung Park, Jae-Kyeong Lee, Hyung-Joo Oh, Bo Gun Kho, Ha-Young Park, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hong Joon Shin
Usefulness of Mycobacterium tuberculosis-polymerase chain reaction with bronchial washing samples in predicting discontinuation of airborne infection isolation in patients hospitalized with suspected pulmonary tuberculosis. PloS one 17 (12) (2022)
Tae-Ok Kim, Young-Ok Na, Hwa Kyung Park, Jae-Kyeong Lee, Hyung-Joo Oh, Bo Gun Kho, Ha-Young Park, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hong Joon Shin
Usefulness of Mycobacterium tuberculosis-polymerase chain reaction with bronchial washing samples in predicting discontinuation of airborne infection isolation in patients hospitalized with suspected pulmonary tuberculosis. PloS one 17 (12) (2022)
Tae-Ok Kim, Young-Ok Na, Hwa Kyung Park, Jae-Kyeong Lee, Hyung-Joo Oh, Bo Gun Kho, Ha-Young Park, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hong Joon Shin
Usefulness of Mycobacterium tuberculosis-polymerase chain reaction with bronchial washing samples in predicting discontinuation of airborne infection isolation in patients hospitalized with suspected pulmonary tuberculosis. PloS one 17 (12) (2022)
Tae-Ok Kim, Young-Ok Na, Hwa Kyung Park, Jae-Kyeong Lee, Hyung-Joo Oh, Bo Gun Kho, Ha-Young Park, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hong Joon Shin
Usefulness of Mycobacterium tuberculosis-polymerase chain reaction with bronchial washing samples in predicting discontinuation of airborne infection isolation in patients hospitalized with suspected pulmonary tuberculosis. PloS one 17 (12) (2022)
Tae-Ok Kim, Young-Ok Na, Hwa Kyung Park, Jae-Kyeong Lee, Hyung-Joo Oh, Bo Gun Kho, Ha-Young Park, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hong Joon Shin
Usefulness of Mycobacterium tuberculosis-polymerase chain reaction with bronchial washing samples in predicting discontinuation of airborne infection isolation in patients hospitalized with suspected pulmonary tuberculosis. PloS one 17 (12) (2022)
Hayoung Choi, Jae-Kyeong Lee, Hyung-Joo Oh, Min-Seok Kim, Bo Gun Kho, Cheol-Kyu Park, In Jae Oh, Young-Chul Kim
Efficacy and dose of afatinib in patients with non-small cell lung cancer after failure of prior gefitinib or erlotinib treatment. Thoracic cancer 12 (10) (2021)

Hyung-Joo Oh.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hyung-Joo Oh